For 133 cervical cancer patients, HLA-E expression was assessed via tissue cores confined in a TMA; for 74 cervical AC patients, expression was assessed in whole tissue sections (15 AC cases overlap). The gene discussed is HLA-E; the disease is cervical cancer.